Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 231

1.

Diagnostic utility of mammaglobin and GCDFP-15 in the identification of metastatic breast carcinoma in fluid specimens.

Yan Z, Gidley J, Horton D, Roberson J, Eltoum IE, Chhieng DC.

Diagn Cytopathol. 2009 Jul;37(7):475-8. doi: 10.1002/dc.21039.

PMID:
19217055
2.

Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity.

Bhargava R, Beriwal S, Dabbs DJ.

Am J Clin Pathol. 2007 Jan;127(1):103-13.

3.

Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors.

Chia SY, Thike AA, Cheok PY, Tan PH.

Breast. 2010 Oct;19(5):355-9. doi: 10.1016/j.breast.2010.02.007. Epub 2010 Mar 26.

PMID:
20347310
4.

Distinguishing breast carcinoma from Müllerian serous carcinoma with mammaglobin and mesothelin.

Kanner WA, Galgano MT, Stoler MH, Mills SE, Atkins KA.

Int J Gynecol Pathol. 2008 Oct;27(4):491-5. doi: 10.1097/PGP.0b013e31817d5340.

PMID:
18753974
6.

Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens.

Fiel MI, Cernaianu G, Burstein DE, Batheja N.

Acta Cytol. 1996 Jul-Aug;40(4):637-41.

PMID:
8693878
7.
8.

Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary.

Tornos C, Soslow R, Chen S, Akram M, Hummer AJ, Abu-Rustum N, Norton L, Tan LK.

Am J Surg Pathol. 2005 Nov;29(11):1482-9. Erratum in: Am J Surg Pathol. 2006 Jan;30(1):140.

PMID:
16224215
9.

GCDFP-15 positive and TTF-1 negative primary lung neoplasms: a tissue microarray study of 381 primary lung tumors.

Wang LJ, Greaves WO, Sabo E, Noble L, Tavares R, Ng T, DeLellis RA, Resnick MB.

Appl Immunohistochem Mol Morphol. 2009 Dec;17(6):505-11. doi: 10.1097/PAI.0b013e3181a8e809.

PMID:
19620839
10.

Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer.

Fritzsche FR, Thomas A, Winzer KJ, Beyer B, Dankof A, Bellach J, Dahl E, Dietel M, Kristiansen G.

Histol Histopathol. 2007 Nov;22(11):1221-30.

PMID:
17647195
11.

Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast.

Honma N, Takubo K, Arai T, Younes M, Kasumi F, Akiyama F, Sakamoto G.

APMIS. 2006 Oct;114(10):712-9.

PMID:
17004974
12.

GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.

Shield PW, Papadimos DJ, Walsh MD.

Cancer Cytopathol. 2014 Apr;122(4):307-12. doi: 10.1002/cncy.21393. Epub 2014 Jan 13.

13.
14.

Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.

Honma N, Takubo K, Akiyama F, Sawabe M, Arai T, Younes M, Kasumi F, Sakamoto G.

Histopathology. 2005 Aug;47(2):195-201.

PMID:
16045781
15.

Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue.

Satoh F, Umemura S, Osamura RY.

Breast Cancer. 2000 Jan;7(1):49-55.

PMID:
11029771
17.

Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers.

Sasaki E, Tsunoda N, Hatanaka Y, Mori N, Iwata H, Yatabe Y.

Mod Pathol. 2007 Feb;20(2):208-14. Epub 2006 Dec 22.

18.
20.

Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?

Moritani S, Ichihara S, Hasegawa M, Endo T, Oiwa M, Yoshikawa K, Sato Y, Aoyama H, Hayashi T, Kushima R.

Hum Pathol. 2008 May;39(5):666-71. doi: 10.1016/j.humpath.2007.09.009. Epub 2008 Mar 12.

PMID:
18339419
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk